Scan to get started on Sahi

Rethink Trading
A new age Broking platform with in-house Sahi charts, real-time AI intelligence, and flat ₹10 per order brokerage.
4.5 ★ . 38K+ Ratings Google Play and App Store | IFTA Startup of the year 2025 | Forbes Asia Top 100 Startups to Watch 2026 | 8M+ downloads

Built for single-screen high performance acrossOptions Buying
Options Buying
Options Buying
Introducing the new & improved Sahi Scalper 2.0
Analyse & execute on a multi-chart layout. Watch the Index and Option Charts, Call & Put, Option Chain, simultaneously without moving an eye from your P&L.


Seamless Options Trading with Powerful Tools
Stay nimble and execute faster than ever before – no matter the screen size.
Trade from Charts, at Sahi Speed
Sahi’s powerful charts are built in-house & give you full control over your trades. Manage risk, optimize entries and exits, and never miss a movement – all without leaving your chart.

Real-Time market intelligence with Sahi AI
Tracks trends, identifies breakouts, highlights the hottest stocks

Analyse, Trade Option Strategies With Confidence
Create strategies that work for you. More control, better results.

Personalized Trading:
Tailor Your Space and Strategy
Personalize your homepage layout to match your trading style. Set up your workspace the way you want it, with just the tools you need.


High Performance Trading
at Incredible Value
Pay only ₹10 per executed order.
Latest news

Greaves Cotton Expands Global Marine Business via Multiflex Marine at Metstrade 2026
Greaves Cotton is aiming to scale its European and global marine operations under the Multiflex Marine brand, introducing a new hydraulic steering system at Metstrade 2026 (as stated in the source alert; not independently verified). This builds on the company's operational momentum in core engineering solutions.

Tata Technologies Outlines Long-Term Growth Ambitions And Software Scaling Plan
Tata Technologies is targeting long-term topline growth of $1.1–1.3 billion and EBITDA margins over 20% by FY30, alongside plans to double its software unit in 3 years (as stated in the source alert; not independently verified). The goals build on active business execution, with Q2 FY27 operating revenue reaching ₹1,698.8 crore.

Beta Drugs Collaborates With IMGSA Groupe SPA For Oncology Manufacturing In Algeria
Beta Drugs Limited is partnering with IMGSA Groupe SPA for local manufacturing of specialized oncology formulations in Algeria. The collaboration reinforces Beta Drugs' international expansion strategy across key MENA region markets.




